Reven tests anti-sepsis drug for treatment of COVID-19
WESTMINSTER — Reven Holdings Inc., a biosciences company developing potential treatments for cancer, viral illnesses and inflammatory disorders, completed this […]
Source: BizWest
Related Articles
BizWest celebrates 40 years covering business and recognizes 40 iconic leaders who inspired the region’s development.
View related stories: Click here to view the 40th Anniversary supplement. ‘Turnpike’ helps define how economy has changed Wood: Preserving…
ARCA Biopharma submits anti-blood clotting drug to FDA as potential COVID treatment
WESTMINSTER — Gene therapy maker ARCA biopharma Inc. (Nasdaq: ABIO) has filed an initial application to study whether its anti-blood…
Boulder’s Arpeggio Bioscience raises $17M Series A to bolster drug trials
BOULDER — Arpeggio Bioscience Inc., a preclinical-stage pharmaceutical company founded by University of Colorado Boulder doctoral program graduates, has raised…
Biotechnology boom
The COVID-19 pandemic — and its seemingly never-ending aftermath — has been a nightmare for commercial landlords of many different…
Flatiron Park’s next phase
BOULDER — So, it’s early 2022, COVID-19 is wreaking havoc on the market for office space, and you’ve just made…